非酒精性脂肪肝和肝硬化如何影响心脏
Søren Møller1,2, Signe Wiese3, Mads Barløse4
1Department Clinical Physiology and Nuclear Medicine 260, Center for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Copenhagen University Hospital, Kettegaards alle 30, 2650, Hvidovre, Denmark. soeren.moeller@regionh.dk.
像NAFLD和肝硬化等肝脏疾病显著影响心脏健康,增加心血管风险. 了解这些联系对于患者的诊断和治疗至关重要.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 肝脏疾病,包括非酒精性脂肪肝 (NAFLD) 和肝硬化,越来越多地与心血管并发症有关.
- 心血管问题是晚期肝病患者死亡的主要原因.
- 肝脏组织学变化 (肥胖症,纤维化,肝硬化) 不同地影响心血管系统.
研究的目的:
- 审查目前对肝病与心血管并发症之间的关系的理解.
- 探索涉及肝硬化心肌病 (CCM) 和NAFLD相关心血管风险的独特病理生理机制.
- 强调对高危患者进行准确诊断评估的重要性.
主要方法:
- 关于肝病和心血管相互作用的当前研究的文献综述.
- 分析病理生理机制,将肝脏组织学与心脏功能障碍联系起来.
- 讨论风险评估和治疗评估的诊断方式.
主要成果:
- 患有CCM和NAFLD的患者面临缩/腹缩功能障碍和主要心血管事件的风险增加.
- 病理生理机制根据具体的肝病及其阶段而有所不同.
- 早期和准确的症状评估对于患者管理至关重要.
结论:
- 心血管并发症是NAFLD和肝硬化患者的关键问题.
- 了解这些风险背后的具体机制对于有效的临床管理至关重要.
- 现代诊断工具对于识别和管理风险人群是不可或缺的.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
